Overall, our in silico investigation elucidated that Danshen may alleviate the development of dyslipidemia into ASCVD by suppressing macrophage polarization, apoptosis, and smooth muscle cell proliferation via modulating PI3K/Akt. This evidence concerns the gene AKT1 and metabolic syndrome.